Skip to main content
Alexander Kabanov receives millions from NIH to develop effective therapeutics for triple-negative breast cancer – UNC Eshelman School of Pharmacy

Alexander Kabanov receives millions from NIH to develop effective therapeutics for triple-negative breast cancer

Alexander “Sasha” Kabanov, Ph.D., Dr.Sci., recently received funding from the National Institutes of Health’s National Cancer Institute to help combat triple-negative breast cancer, a disease that has fewer treatment options than other types of breast cancer. The four-year funding totaling … Continue reading Alexander Kabanov receives millions from NIH to develop effective therapeutics for triple-negative breast cancer